EGFR and cancer: Furthermore, significantly co-occurring alterations in FADD CCND1, FGF19, and ORAOV1 (P < 0.0001) were found to occur mutually exclusive with EGFR amplification among HPV-negative early TSCC tumors, as previously described in other cancers [6], [7].